Published in Medical Letter on the CDC and FDA, February 6th, 2005
Additional information in support of and to provide the rationale for the phase III trial (final reports of clinical trials conducted with Multikine to date and manufacturing and testing information) was included with this submission.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.